These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22587365)

  • 1. Correlation of fasting serum apolipoprotein B-48 with coronary artery disease prevalence.
    Masuda D; Sugimoto T; Tsujii K; Inagaki M; Nakatani K; Yuasa-Kawase M; Tsubakio-Yamamoto K; Ohama T; Nishida M; Ishigami M; Kawamoto T; Matsuyama A; Sakai N; Komuro I; Yamashita S
    Eur J Clin Invest; 2012 Sep; 42(9):992-9. PubMed ID: 22587365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice.
    Alipour A; Valdivielso P; Elte JW; Janssen HW; Rioja J; van der Meulen N; van Mechelen R; Njo TL; González-Santos P; Rietveld AP; Cabezas MC
    Eur J Clin Invest; 2012 Jul; 42(7):702-8. PubMed ID: 22224712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of lipids and apolipoproteins in angiographycally defined ischemic heart disease.
    Shima K; Tanaka A; Ejiri N; Maezawa H
    Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):169-77. PubMed ID: 3865743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting apoprotein B-48 level and coronary artery disease in a population without frank fasting hypertriglyceridemia.
    Valero R; Lorec AM; Paganelli F; Beliard S; Atlan C; Lairon D; Vialettes B; Portugal H
    Metabolism; 2005 Nov; 54(11):1442-7. PubMed ID: 16253631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease.
    Duman BS; Türkoğlu C; Akpinar B; Güden M; Vertii A; Cağatay P; Günay D; Sevim Büyükdevrim A
    Ann Hum Biol; 2005; 32(5):620-9. PubMed ID: 16316917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
    Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.
    Stompór T; Pasowicz M; Sulłowicz W; Dembińska-Kieć A; Janda K; Wójcik K; Tracz W; Zdzienicka A; Klimeczek P; Janusz-Grzybowska E
    Am J Kidney Dis; 2003 Jan; 41(1):203-11. PubMed ID: 12500238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
    Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
    Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
    Habib SS
    J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
    Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
    Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
    Rasouli M; Kiasari AM
    Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evidence for chylomicrons as mediators of postprandial inflammation.
    de Vries MA; Klop B; Alipour A; van de Geijn GJ; Prinzen L; Liem AH; Valdivielso P; Rioja Villodres J; Ramírez-Bollero J; Castro Cabezas M
    Atherosclerosis; 2015 Dec; 243(2):540-5. PubMed ID: 26523991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association between adipocyte fatty acid binding proteins/adiponectin and coronary artery stenosis].
    Jin J; Peng DQ; Gong H; Zhao SP; Ning XH; Li SL; Wang SH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Aug; 38(8):706-10. PubMed ID: 21055137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid profile in patients with coronary artery disease.
    Haddad FH; Omari AA; Shamailah QM; Malkawi OM; Shehab AI; Mudabber HK; Shubaki MK
    Saudi Med J; 2002 Sep; 23(9):1054-8. PubMed ID: 12370711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
    Bukowska H
    Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.